Vupparapalli Chandrasekhar Reddy Increases Holding in Novelix Pharmaceuticals Following Warrant Conversion
A significant allotment of equity shares has been reported in Novelix Pharmaceuticals Limited, following the conversion of warrants issued to Promoter members.The transaction relates to Vupparapalli Chandrasekhar Reddy and his partners, who were allotted 5,60,000 Equity Shares on May 29, 2026. The allotment occurred pursuant to the conversion of warrants through a Preferential Allotment basis.
The acquisition details confirm that Vupparapalli Chandrasekhar Reddy and Vupparapalli Pavani hold shares in Novelix Pharmaceuticals Limited as part of the Promoter/Promoter Group.
Acquisition Details Snapshot
The details surrounding the acquisition, including pre-acquisition holdings and post-allotment status, are summarized below:| Metric | Pre-Acquisition Holding (as % of Total Diluted Share Voting Capital) | Post-Acquisition Holding (as % of Total Diluted Share Voting Capital) |
|---|---|---|
| Acquirer holding (Vupparapalli Chandrasekhar Reddy & Vupparapalli Pavani) | 13.69% | 13.69% |
| Shares acquired in this transaction | 5,60,000 shares | N/A |
Financial and Capital Structure Post-Acquisition
The conversion of warrants into equity shares resulted in changes to the company's capital structure. Before the acquisition, the Equity Share Capital of Novelix Pharmaceuticals limited stood at Rs. 210,850,000, comprising 21,085,000 Equity Shares. After the said acquisition, the Equity Share Capital was reported as Rs. 238,950,000 (comprising Equity Shares of Rs. 10/- each).The total diluted share or voting capital of the company after this event is stated to be Rs. 272,700,000, which includes 23,895,000 Equity Shares and 33,75,000 outstanding convertible warrants.
Detailed Holding Data
The following table provides a detailed breakdown of the pre-acquisition holdings of Vupparapalli Chandrasekhar Reddy and his co-promoters, and the resulting holding structure after the acquisition:| Category | Details Pre-Acquisition (VCR & Pavani) | Details Post-Acquisition (VCR & Pavani) |
|---|---|---|
| Total Shares Acquired in this transaction | 5,60,000 shares | N/A |
| Shares carrying voting rights of Vupparapalli Chandrasekhar Reddy before acquisition | 15,70,733 | 21,30,733 |
| Shares carrying voting rights of Vupparapalli Pavani before acquisition | 7,25,000 | N/A |
| Total shares held before the transaction (VCR & Pavani) | 36,30,733 | N/A |
Stock Price Movement
As of 10:32, Novelix Pharmaceuticals Ltd shares are ticking up at ₹55.97 after rising by 6.27%. The stock has seen significant movement today, trading within an intraday range defined by a low of ₹51.30 and a high of ₹57.50.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.